CARDIOVASCULAR DRUGS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
VALSARTAN & HYDROCHLOROTHIAZIDE: products 1 to 20 of 34.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Valsartan/HCTZ 160mg & 12.5mg TabDIN 02382555 | General benefit | $0.2240per source unit | Requirements & sourcesBuild cost plan |
| Apo-Valsartan/HCTZ 160mg & 25mg TabDIN 02382563 | General benefit | $0.2238per source unit | Requirements & sourcesBuild cost plan |
| Apo-Valsartan/HCTZ 320mg & 12.5mg TabDIN 02382571 | General benefit | $0.2235per source unit | Requirements & sourcesBuild cost plan |
| Apo-Valsartan/HCTZ 320mg & 25mg TabDIN 02382598 | General benefit | $0.2231per source unit | Requirements & sourcesBuild cost plan |
| Apo-Valsartan/HCTZ 80mg & 12.5mg TabDIN 02382547 | General benefit | $0.2213per source unit | Requirements & sourcesBuild cost plan |
| Auro-Valsartan HCT 160mg & 12.5mg TabDIN 02408120 | General benefit | $0.2240per source unit | Requirements & sourcesBuild cost plan |
| Auro-Valsartan HCT 160mg & 25mg TabDIN 02408139 | General benefit | $0.2238per source unit | Requirements & sourcesBuild cost plan |
| Auro-Valsartan HCT 320mg & 12.5mg TabDIN 02408147 | General benefit | $0.2235per source unit | Requirements & sourcesBuild cost plan |
| Auro-Valsartan HCT 320mg & 25mg TabDIN 02408155 | General benefit | $0.2231per source unit | Requirements & sourcesBuild cost plan |
| Auro-Valsartan HCT 80mg & 12.5mg TabDIN 02408112 | General benefit | $0.2213per source unit | Requirements & sourcesBuild cost plan |
| Diovan-HCT 160mg & 12.5mg TabDIN 02241901 | General benefit | $0.2240per source unit | Requirements & sourcesBuild cost plan |
| Diovan-HCT 160mg & 25mg TabDIN 02246955 | General benefit | $0.2238per source unit | Requirements & sourcesBuild cost plan |
| Diovan-HCT 320mg & 12.5mg TabDIN 02308908 | General benefit | $0.2235per source unit | Requirements & sourcesBuild cost plan |
| Diovan-HCT 320mg & 25mg TabDIN 02308916 | General benefit | $0.2231per source unit | Requirements & sourcesBuild cost plan |
| Diovan-HCT 80mg & 12.5mg TabDIN 02241900 | General benefit | $0.2213per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Valsartan HCT 160mg & 12.5mg TabDIN 02356708 | General benefit | $0.2240per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Valsartan HCT 160mg & 25mg TabDIN 02356716 | General benefit | $0.2238per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Valsartan HCT 320mg & 12.5mg TabDIN 02356724 | General benefit | $0.2235per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Valsartan HCT 320mg & 25mg TabDIN 02356732 | General benefit | $0.2231per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Valsartan HCT 80mg & 12.5mg TabDIN 02356694 | General benefit | $0.2213per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:04 Cardiac Drugs.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.
24:12 Vasodilating Drugs.
24:32:08 Angiotensin II Receptor Antagonists.